<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 14 Feb 2024 16:27:22 -0500--><rss version="2.0">
    <channel>
        <title>Nighthawk Biosciences, Inc. (SCPX) SEC Filings</title>
        <link>https://www.nighthawkbio.com/investors-news/sec-filings/annual-reports/rss</link>
        <description>Nighthawk Biosciences, Inc. (SCPX) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/nighthawkbio/files/theme/images/logo-sm.png</url>
                <title>Nighthawk Biosciences, Inc. Logo</title>
                <link>/investors-news</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-015270/0001558370-23-015270.pdf</link>
                <pubDate>Fri, 25 Aug 23 16:28:25 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-015270/0001558370-23-015270.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-10.62, EX-10.63, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-005289/0001558370-23-005289.pdf</link>
                <pubDate>Fri, 31 Mar 23 16:25:49 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-005289/0001558370-23-005289.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[15 Related Documents: 10-K, EX-4.19, EX-10.22, EX-10.23, EX-10.24, EX-10.25, EX-10.26, EX-10.27, EX-10.28, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-003452/0001558370-22-003452.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:30:00 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-003452/0001558370-22-003452.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.20, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-003460/0001558370-21-003460.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:27:56 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-003460/0001558370-21-003460.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.20, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-20-000252/0001553350-20-000252.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:22:52 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-20-000252/0001553350-20-000252.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-K/A, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-19-000432/0001553350-19-000432.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:18:27 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-19-000432/0001553350-19-000432.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-19-000267/0001553350-19-000267.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:17:35 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-19-000267/0001553350-19-000267.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[10 Related Documents: 10-K, EX-10.77, EX-10.78, EX-10.79, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-18-000174/0001553350-18-000174.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:13:36 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-18-000174/0001553350-18-000174.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-10.67, EX-10.68, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-17-000337/0001553350-17-000337.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:09:49 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-17-000337/0001553350-17-000337.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-16-001596/0001553350-16-001596.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:04:42 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001553350-16-001596/0001553350-16-001596.pdf</guid>
                                                                            </item>
            </channel>
</rss>